Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

platinum-resistant ovarian cancer

Onco_background

Oncology Today—February 16, 2026

This week's Oncology update covers regulatory actions, clinical trial progress,…

Oncology News

Oncology Video Recap—January 5, 2026

This Oncology video recap covering news from the last thre weeks brings…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in localized prostate cancer
Public Health Today—February 20, 2026
Vaccines Video Recap—February 20, 2026
Vaccines Today—February 20, 2026
Respiratory Video Recap—February 20, 2026

Tags

adult-onset Still’s disease brain metastases calcification biology cancer Cancer drug development Cardamyst combinations Compositionality research Cytokine release syndrome EGFR-mutated non-small cell lung cancer Elranatamab erumo FDA accelerated approval FDA endocrinology approvals GenSight Biologics Gosta Labs HA fillers hematology Hematology market trends hepatitis D hereditary antithrombin deficiency Histology AI iqvia kidney cancer Lupin Minimally invasive surgery mrsa infection Nipocalimab non viral vectors Obesity market trends OHSU osteogenesis imperfecta Peptinov pharma pharmaceutical strategy PULSAR Portugal Respiree Sapien M3 Sema4 SSi Mantra surgical robotics Triple-negative breast cancer Tysabri uterine sarcoma Venous thromboembolism

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in localized prostate cancer
Public Health Today—February 20, 2026
Vaccines Video Recap—February 20, 2026
Vaccines Today—February 20, 2026
Respiratory Video Recap—February 20, 2026

TAGS

adult-onset Still’s disease brain metastases calcification biology cancer Cancer drug development Cardamyst combinations Compositionality research Cytokine release syndrome EGFR-mutated non-small cell lung cancer Elranatamab erumo FDA accelerated approval FDA endocrinology approvals GenSight Biologics Gosta Labs HA fillers hematology Hematology market trends hepatitis D hereditary antithrombin deficiency Histology AI iqvia kidney cancer Lupin Minimally invasive surgery mrsa infection Nipocalimab non viral vectors Obesity market trends OHSU osteogenesis imperfecta Peptinov pharma pharmaceutical strategy PULSAR Portugal Respiree Sapien M3 Sema4 SSi Mantra surgical robotics Triple-negative breast cancer Tysabri uterine sarcoma Venous thromboembolism

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy